Vijaya Diagnostic Centre Schedules Analyst and Institutional Investor Meetings on May 20-21, 2026

1 min read     Updated on 12 May 2026, 01:14 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Vijaya Diagnostic Centre Limited has scheduled analyst and institutional investor meetings on May 20 and May 21, 2026, pursuant to SEBI Regulation 30. The May 20 meeting with Centrum Broking will be held virtually, while the May 21 meeting with Yes Securities will take place in person in Mumbai. The company has confirmed that all discussions will be based on publicly available information, with no unpublished price-sensitive information to be disclosed. The intimation was filed on May 12, 2026, by Chief Financial Officer Ankit Shah.

powered bylight_fuzz_icon
40117472

*this image is generated using AI for illustrative purposes only.

Vijaya Diagnostic Centre Limited has notified the stock exchanges of two analyst and institutional investor meetings scheduled on May 20 and May 21, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on May 12, 2026, and signed by Ankit Shah, Chief Financial Officer of the company.

Scheduled Meetings at a Glance

The company's officials are set to interact with institutional investors and analysts across two separate events over consecutive days. The following table outlines the key details of each meeting:

Parameter: Meeting 1 Meeting 2
Date: Wednesday, May 20, 2026 Thursday, May 21, 2026
Time (IST): 10:00 A.M. to 11:00 A.M. 10:00 A.M. to 02:00 P.M.
Organisation: Centrum Broking Yes Securities, India
Event Name: Nakshatra III – Shining Stars Amid Global Turbulence Manthan 2026: Rising Soft Power; Compelling Growth Stories
Type of Meeting: Group Meeting Group/One on One Meeting – In Person
Venue: Virtual Mumbai

Key Disclosures and Conditions

The company has outlined several important conditions governing these meetings:

  • All discussions will be based solely on publicly available information, and no unpublished price-sensitive information will be shared during the meetings.
  • The schedule of the analyst and institutional investor meetings is subject to change, which may occur due to exigencies on the part of participants or the company.
  • Investors and analysts may subsequently approach the company for any clarifications regarding discussions held during the meetings.

The disclosure is available on the company's investor relations website at https://www.vijayadiagnostic.com/investors/disclosure-of-events .

Historical Stock Returns for Vijaya Diagnostic Centre

1 Day5 Days1 Month6 Months1 Year5 Years
-1.71%+6.68%+28.23%+21.97%+30.90%+104.79%

What strategic growth initiatives or expansion plans might Vijaya Diagnostic Centre highlight to institutional investors amid the current global market turbulence?

How could increased institutional investor interest following these meetings potentially impact Vijaya Diagnostic Centre's stock liquidity and valuation multiples?

What key financial metrics or operational milestones is Vijaya Diagnostic Centre likely to emphasize to differentiate itself as a 'compelling growth story' in India's diagnostics sector?

Vijaya Diagnostic Centre
View Company Insights
View All News
like15
dislike

Vijaya Diagnostic Centre Shareholders Approve Two Independent Directors via Postal Ballot

4 min read     Updated on 12 May 2026, 07:49 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Vijaya Diagnostic Centre Limited concluded its postal ballot process with shareholders approving the appointment of Mr. Ravi Shankararamiah (DIN: 00180746) and Dr. Sasikala Paruchuri Kola (DIN: 00129614) as Independent Directors through Special Resolutions on May 09, 2026. Resolution 1 received 99.9994% votes in favour with 9,62,32,872 valid votes, while Resolution 2 received 99.9995% votes in favour with 9,62,33,049 valid votes, out of 63,545 total shareholders on record as of April 03, 2026.

powered bylight_fuzz_icon
40038366

*this image is generated using AI for illustrative purposes only.

Vijaya Diagnostic Centre Limited has successfully concluded its postal ballot process, with shareholders approving the appointment of two new Independent Directors through Special Resolutions passed on May 09, 2026. The resolutions, as set out in the Postal Ballot Notice dated February 13, 2026, received requisite majority approval from the company's members. The voting results and scrutinizer's report were submitted to the stock exchanges on April 11, 2026, by Chief Financial Officer Ankit Shah.

Postal Ballot Process Overview

The company dispatched the Notice of Postal Ballot electronically to all registered members on April 09, 2026, based on the list of shareholders as on the cut-off date of April 03, 2026. A total of 63,545 shareholders were on record as of the cut-off date. The e-voting window opened on Friday, April 10, 2026 at 9:00 AM (IST) and closed on Saturday, May 09, 2026 at 5:00 PM (IST). The e-voting facility was provided by KFin Technologies Limited. In compliance with applicable MCA Circulars, physical Postal Ballot Forms were not dispatched, and no physical postal ballot forms were received.

The scrutinizer for the postal ballot process was Balaramakrishna Desina, Proprietor of Balaramakrishna & Associates, Company Secretaries in Practice, Hyderabad, appointed by the Board of Directors in its meeting held on February 13, 2026. The scrutinizer's report was issued to the company on May 09, 2026.

Parameter: Details
Record Date: April 03, 2026
Total Shareholders on Record Date: 63,545
E-Voting Start: April 10, 2026, 9:00 AM (IST)
E-Voting End: May 09, 2026, 5:00 PM (IST)
E-Voting Platform: KFin Technologies Limited
Scrutinizer: Balaramakrishna Desina, Balaramakrishna & Associates
No. of Resolutions Passed: 2

Resolution 1: Appointment of Mr. Ravi Shankararamiah as Independent Director

The first Special Resolution pertained to the appointment of Mr. Ravi Shankararamiah (DIN: 00180746) as an Independent Director of the company. The promoter and promoter group were not interested in this resolution. The resolution was passed with requisite majority, with 99.9994% of total valid votes cast in favour.

The following table presents the detailed voting results for Resolution 1:

Category: Shares Held Votes Polled % Polled Votes in Favour Votes Against % in Favour % Against
Promoter & Promoter Group: 54033156 54000372 99.9393 54000372 0 100.0000 0.0000
Public – Institutions: 44574459 42218454 94.7145 42218454 0 100.0000 0.0000
Public – Non Institutions: 4289113 14669 0.3420 14046 623 95.7529 4.2471
Total: 102896728 96233495 93.5243 96232872 623 99.9994 0.0006

Summary of votes in favour (Resolution 1): 402 members cast 9,62,32,872 valid votes in favour, representing 99.9994% of total valid votes. Votes against: 12 members cast 623 valid votes against, representing 0.0006%. Invalid/Abstained/Not Voted: 5 members holding 2,033 shares.

Resolution 2: Appointment of Dr. Sasikala Paruchuri Kola as Independent Director

The second Special Resolution concerned the appointment of Dr. Sasikala Paruchuri Kola (DIN: 00129614) as an Independent Director of the company. The promoter and promoter group were not interested in this resolution either. The resolution was passed with requisite majority, with 99.9995% of total valid votes cast in favour.

The detailed voting results for Resolution 2 are as follows:

Category: Shares Held Votes Polled % Polled Votes in Favour Votes Against % in Favour % Against
Promoter & Promoter Group: 54033156 54000372 99.9393 54000372 0 100.0000 0.0000
Public – Institutions: 44574459 42218454 94.7145 42218454 0 100.0000 0.0000
Public – Non Institutions: 4289113 14667 0.3420 14223 444 96.9728 3.0272
Total: 102896728 96233493 93.5243 96233049 444 99.9995 0.0005

Summary of votes in favour (Resolution 2): 403 members cast 9,62,33,049 valid votes in favour, representing 99.9995% of total valid votes. Votes against: 11 members cast 444 valid votes against, representing 0.0005%. Invalid/Abstained/Not Voted: 5 members holding 2,035 shares.

Scrutinizer's Findings

Balaramakrishna Desina, in his report dated May 09, 2026, confirmed that both resolutions mentioned in the Postal Ballot Notice stand passed with the requisite majority as of Saturday, May 09, 2026, being the last date fixed for e-voting. The votes cast by members through e-voting were reconciled with records maintained by the Registrar and Transfer Agent of the company. No physical postal ballot forms were received or processed during the exercise.

Historical Stock Returns for Vijaya Diagnostic Centre

1 Day5 Days1 Month6 Months1 Year5 Years
-1.71%+6.68%+28.23%+21.97%+30.90%+104.79%

How might the addition of Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola strengthen Vijaya Diagnostic Centre's board committees, particularly in areas like audit, risk management, or clinical governance?

Could the strengthened independent board composition influence Vijaya Diagnostic Centre's strategic decisions around expansion, acquisitions, or new diagnostic service offerings?

What impact might the enhanced corporate governance structure have on institutional investor confidence and Vijaya Diagnostic Centre's stock performance in the near term?

Vijaya Diagnostic Centre
View Company Insights
View All News
like19
dislike

More News on Vijaya Diagnostic Centre

1 Year Returns:+30.90%